ethinyl estradiol has been researched along with nafarelin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisher, M; Greendale, GA; Heiner, JS; Judd, HL; Kawakami, AK; Lapolt, PS; Young, D | 1 |
Adams, SM; Gayer, N; Hosie, MJ; Murphy, CR; Terry, V | 1 |
Healy, D; Norman, RJ; Rombauts, L | 1 |
Bernstein, DI; Bernstein, IL; Bernstein, JA; Lummus, ZL | 1 |
3 trial(s) available for ethinyl estradiol and nafarelin
Article | Year |
---|---|
Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
Topics: Adult; Contraceptives, Oral; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Hair; Hirsutism; Humans; Middle Aged; Nafarelin; Norethindrone; Treatment Outcome | 1995 |
Endometrial response to IVF hormonal manipulation: comparative analysis of menopausal, down regulated and natural cycles.
Topics: Adult; Biopsy; Endometrium; Epithelial Cells; Estradiol; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicular Phase; Hormones; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Nafarelin; Progesterone | 2004 |
A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients.
Topics: Adolescent; Adult; Cell Count; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Embryo, Mammalian; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormones; Humans; Luteinizing Hormone; Nafarelin; Oocytes; Ovarian Follicle; Ovulation Induction | 2006 |
1 other study(ies) available for ethinyl estradiol and nafarelin
Article | Year |
---|---|
A case of progesterone-induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis.
Topics: Anaphylaxis; Angioedema; Animals; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dermatitis; Drug Eruptions; Enzyme-Linked Immunosorbent Assay; Estrogens; Ethinyl Estradiol; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Immunoglobulin E; Immunoglobulin G; Mice; Middle Aged; Mifepristone; Nafarelin; Norethindrone; Progesterone; Urticaria | 2011 |